Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Protein & Cell
>
2021
>
12
>
5
Volume:
12
Issue:
5
1. A practical guide to amplicon and metagenomic analysis of microbiome data.
Page:315—330
2. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.
Page:331—345
3. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.
Page:374—393
4. Role of gut microbiota in identification of novel TCM-derived active metabolites.
Page:394—410
5. Gut microbes in cardiovascular diseases and their potential therapeutic applications.
Page:346—359
6. Targeting the alternative bile acid synthetic pathway for metabolic diseases.
Page:411—425
7. Unexpected guests in the tumor microenvironment: microbiome in cancer.
Page:426—435
8. The role of the gut microbiome and its metabolites in metabolic diseases.
Page:360—373